PUBLISHER: The Business Research Company | PRODUCT CODE: 1945278
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945278
Hematology diagnostic devices and equipment are critical medical tools used to analyze blood samples for detecting and diagnosing various conditions and diseases. These devices play a vital role in identifying disorders such as anemia, leukemia, and other blood-related conditions. Advances in these technologies have significantly enhanced the accuracy, speed, and efficiency of hematological testing, enabling healthcare professionals to make timely and informed clinical decisions.
The primary product categories within hematology diagnostics devices and equipment encompass instruments and consumables. Hematology diagnostic instruments are employed to diagnose a wide range of conditions associated with the blood, vascular systems, bone marrow, autoimmune disorders, and hemostasis. Hematology diagnostics consumables consist of reagents, stains, and other related materials, while the instruments include analyzers, flow cytometers, and various other diagnostic devices. These tools find applications in diverse medical fields, including drug testing, autoimmune disease diagnostics, cancer detection, diabetes mellitus monitoring, infectious disease testing, and more. They are utilized by a range of end-users, such as hospitals, specialized diagnostic centers, and dedicated research institutes.
Tariffs are impacting the hematology diagnostic devices and equipment market by increasing costs of imported analyzers, flow cytometers, electronic components, reagents, and precision sensors. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported instruments, while Asia-Pacific faces cost pressure on equipment exports. These tariffs are raising capital and operating costs for diagnostic providers. However, they are also driving local manufacturing, regional reagent production, and increased investment in domestically developed diagnostic technologies.
The hematology diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hematology diagnostic devices and equipment market statistics, including hematology diagnostic devices and equipment industry global market size, regional shares, competitors with a hematology diagnostic devices and equipment market share, detailed hematology diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hematology diagnostic devices and equipment industry. This hematology diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hematology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $8.29 billion in 2025 to $9.13 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of blood disorders, expansion of clinical diagnostic laboratories, growing demand for routine blood testing, improvements in laboratory automation, availability of standardized hematology reagents.
The hematology diagnostic devices and equipment market size is expected to see strong growth in the next few years. It will grow to $12.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted diagnostics, rising demand for point-of-care hematology testing, expansion of personalized medicine approaches, growing investments in laboratory automation, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of automated hematology analyzers, rising demand for high-throughput blood testing systems, growing use of advanced flow cytometry, expansion of integrated diagnostic platforms, enhanced focus on diagnostic accuracy and speed.
The rising prevalence of blood disorders is expected to drive growth in the hematology diagnostics devices and equipment market. Blood disorders are conditions that affect the count and function of blood cells, including red blood cells, white blood cells, and platelets. Their incidence is increasing, particularly among aging populations who are at higher risk of developing hematologic conditions. Hematology diagnostic devices help address this growing need by enabling early detection, accurate classification, and ongoing monitoring of abnormal blood conditions, facilitating timely treatment. For example, the Canadian Cancer Society, a Canada-based charity, projects that approximately 23,600 Canadians will be diagnosed with blood cancer in 2024. Consequently, the rising prevalence of blood disorders is driving the expansion of the hematology diagnostics devices and equipment market.
The increasing incidence of chronic diseases is further fueling market growth. Chronic diseases-such as cardiovascular conditions, diabetes, cancer, and chronic respiratory disorders-progress over time and require continuous monitoring and management. As the global burden of these illnesses grows, healthcare systems increasingly rely on hematology diagnostic devices to assess blood parameters, detect abnormalities, and guide treatment decisions. Hematology analyzers and related diagnostic equipment play a critical role in monitoring disease progression, supporting therapy planning, and identifying complications early. For example, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, by 2050, the number of individuals aged 50 years and older with at least one chronic disease is expected to increase by 99.5 to 142.66 million. As a result, the growing prevalence of chronic diseases is contributing to the expansion of the hematology diagnostics market.
Companies in the market are also focusing on innovative product development to maintain a competitive edge. Hematology analyzers are specialized devices used in clinical laboratories and healthcare settings to automate the analysis of blood samples. For instance, in May 2023, Siemens Healthineers, a Germany-based healthcare company, launched the Atellica HEMA 570 and Atellica HEMA 580 Analyzers. These devices are designed to optimize high-volume hematology testing through automation, integrated intelligence, and user-friendly interfaces. Capable of processing up to 120 tests per hour, they enable healthcare professionals to interpret complex patient results more efficiently, integrate results directly into laboratory information systems, and receive guidance for follow-up actions when necessary, ultimately enhancing patient care.
Major companies operating in the hematology diagnostic devices and equipment market are Abbott Diagnostics, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Drucker Diagnostics Inc., Horiba Ltd., Instrumentation Laboratory Inc., Siemens Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., HemoCue AB, Mindray Medical International Limited, Danaher Corporation, Edan Instruments Inc., Sysmex Corporation, CellaVision, Maccura Biotechnology Co., DY mind Biotech, Balio Diagnostics, BioSystems Diagnostics Pvt. Ltd., Wiener Lab, Accurex Biomedical Pvt. Ltd., ARKRAY USA, Boule Diagnostics AB, Diatron Group, EKF Diagnostics Holdings, Grifols S.A., Nihon Kohden Corporation, Ortho Clinical Diagnostics, PixCell Medical, STRATEC Biomedical AG, Terumo BCT
North America was the largest region in the global hematology diagnostics devices and equipment market in 2025. Asia-Pacific was the second-largest region in the hematology diagnostics devices and equipment market. The regions covered in the hematology diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hematology diagnostic devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The hematology diagnostic devices and equipment market consists of sales of flow cytometers, slide strainers, automated cell counters, red cell indices devices, micro sedimentation centrifuges, or blood volume measuring devices, occult blood tests, platelet aggregometer, erythrocyte sedimentation rate tests, red blood cell enzyme assay kits, glutathione reductase assays, and hematology reagents that are used for the diagnosis of hematology. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hematology Diagnostic Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hematology diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hematology diagnostic devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematology diagnostic devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.